Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
GlobeNewswire
Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences
February 2, 2021 -
PR Newswire
VitalCDM® Ranked #1 in KLAS Revenue Cycle, Chargemaster Management Category for Third Year in a Row
February 2, 2021 -
PR Newswire
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Pemetrexed and Platinum Chemotherapy as First-Line Therapy for Nonsquamous Non-Small Cell Lung Cancer
February 2, 2021 -
GlobeNewswire
Junshi Biosciences and Coherus BioSciences Announce Collaboration to Co-Develop Anti-PD-1 Antibody, Toripalimab, in U.S. and Canada
February 1, 2021 -
Business Wire
Exelixis and Adagene Enter into Collaboration and License Agreement to Develop Novel Masked Antibody-Drug Conjugate Therapies with Improved Safety and Efficacy Profiles
February 1, 2021 -
GlobeNewswire
Orchard Therapeutics Appoints Braden Parker as Chief Commercial Officer
January 29, 2021 -
GlobeNewswire
ONTOZRY™ (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults
January 29, 2021 -
PR Newswire
Farapulse Receives European Approval To Commercialize Its Leading Pulsed Field Ablation System To Treat Paroxysmal Atrial Fibrillation
January 29, 2021 -
Business Wire
SonderMind Adds Chief Financial and Chief Product Officer to Senior Management Team
January 28, 2021 -
GlobeNewswire
Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less
January 28, 2021 -
PR Newswire
Citrine Medicine Announces Strategic Partnership to bring Alkindi® to China for Use in Pediatric Congenital Adrenal Hyperplasia (CAH)
January 27, 2021 -
PR Newswire
Benchling Launches Validated Cloud to Accelerate Product Development for Life Sciences
January 26, 2021 -
PR Newswire
Hurdle Raises $5 Million Series Seed to Accelerate Expansion of its Mental Health Platform with Special Focus on the Black Community
January 25, 2021 -
GlobeNewswire
Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX701, a New Gene Therapy for the Treatment of Wilson Disease
January 21, 2021 -
PR Newswire
Avidity Biosciences Appoints W. Michael Flanagan, Ph.D. as Chief Technical Officer
January 21, 2021 -
PR Newswire
Iora Health Strengthens Executive Team with CFO and CGO Hires
January 20, 2021 -
Business Wire
Turnstone Biologics Acquires Novel Cell Therapy Platform
January 20, 2021 -
GlobeNewswire
Acacia Pharma wins BEL Small Company of the Year for the second consecutive year
January 20, 2021 -
FierceBiotech
Adagene plans $125M IPO to go after cancer niches targeted by BMS and Pfizer
January 20, 2021 -
GlobeNewswire
Precision BioSciences Announces FDA Accepts IND for PBCAR19B, a Next-Generation, Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma
January 19, 2021 -
Business Wire
Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline of Gene Editing Medicines for Cardiovascular Disease
January 19, 2021 -
GlobeNewswire
Orchard Therapeutics Secures Partnerships to Broaden Access to LibmeldyTM for Eligible Patients in Middle East & Turkey
January 19, 2021 -
PR Newswire
Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia
January 18, 2021 -
PR Newswire
Notable Health First to Launch Automated Identification and Engagement of Patients Eligible for COVID-19 Vaccine
January 14, 2021 -
Business Wire
Kyruus Enables Online Scheduling for COVID-19 Vaccine Visits and Facilitates More Than 100,000 Appointments in the First Month
January 14, 2021 -
Business Wire
Novaerus Defend 1050 Cleared by FDA as 510(k) Class II Medical Device to Inactivate and Filter Out Airborne Virus and Bacteria for Medical Purposes
January 14, 2021 -
PR Newswire
Benchling Doubles Annual Recurring Revenue (ARR) for Fourth Straight Year Amid COVID-19 Pandemic
January 14, 2021 -
GlobeNewswire
Orchard Therapeutics Announces OTL-200 Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by FDA for the Treatment of Metachromatic Leukodystrophy (MLD)
January 14, 2021 -
Endpoints News
Adaptimmune ‘ready for primetime’ as it prepares to launch T cell therapy for sarcoma, CEO Adrian Rawcliffe says
January 13, 2021 -
BioSpace
Emerging Seattle-Based Sana Biotechnology Seeks to Raise $150 Million IPO
January 13, 2021 -
PR Newswire
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer
January 12, 2021 -
FierceBiotech
Verve Therapeutics unveils its lead program—a one-and-done treatment for genetic high cholesterol
January 12, 2021 -
GlobeNewswire
Adagene Announces Milestone of CAR-T Collaboration with the National Heart, Lung, and Blood Institute at the National Institutes of Health
January 12, 2021 -
PR Newswire
Centivo Expands Health Partnerships in New York and New Jersey
January 12, 2021 -
FierceBiotech
Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling
January 11, 2021 -
GlobeNewswire
Orchard Therapeutics Announces 2021 Corporate Priorities Supporting the Build-out of its Commercial Business in Hematopoietic Stem Cell (HSC) Gene Therapy and Expansion of its Clinical Applications
January 11, 2021 -
PR Newswire
Avidity Biosciences Announces Changes to its Board of Directors
January 11, 2021 -
GlobeNewswire
Denali Therapeutics Announces Appointment of Nancy Thornberry to Board of Directors
January 11, 2021 -
GlobeNewswire
Beam Therapeutics Appoints Leading Healthcare Executive Kate Walsh to its Board of Directors
January 11, 2021 -
PR Newswire
Sana Biotechnology Announces Appointments to its Board of Directors
January 8, 2021 -
PR Newswire
Avidity Biosciences Announces 2021 Pipeline Updates and Research Collaboration with MyoKardia
January 8, 2021 -
GlobeNewswire
Denali Therapeutics Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Broad Therapeutic Portfolio in Neurodegeneration
January 8, 2021 -
GlobeNewswire
Precision BioSciences Announces Closing of In Vivo Gene Editing Collaboration and License Agreement with Eli Lilly and Company
January 7, 2021 -
GlobeNewswire
Coherus BioSciences Appoints Alan Mendelson and Mark Stolper to Board of Directors
January 7, 2021 -
PR Newswire
Sana Biotechnology Builds Key Regulatory Capabilities as Ke Liu, M.D., Ph.D., Joins Senior Leadership Team
January 6, 2021 -
PR Newswire
Cigna Adds Iora Health to Growing Medicare Advantage Network
January 6, 2021 -
PR Newswire
Angelini Pharma acquires Arvelle Therapeutics to create a leading European innovator in Central Nervous System (CNS) and Mental Health Disorder treatments
January 4, 2021 -
PR Newswire
Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar) for the Treatment of Adult Recurrent Glioblastoma
December 27, 2020 -
GlobeNewswire
Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
December 21, 2020 -
PR Newswire
FARAPULSE’s Pivotal Trial to Assess Its Leading Pulsed Field Ablation System for The Treatment of Atrial Fibrillation Receives FDA Conditional Approval
December 17, 2020 -
Business Wire
Kyruus and HealthSparq Come Together to Transform Care Navigation Through Novel Payer-Provider Collaboration
December 17, 2020 -
Endpoints News
GlaxoSmithKline plumbs the discovery field (again), betting up to $815M for the latest add-on to its oncology pipeline
December 17, 2020 -
PR Newswire
Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT™ (avapritinib) for the Treatment of Advanced Systemic Mastocytosis
December 17, 2020 -
Business Wire
NodThera Appoints Chief Medical Officer and Chief Financial Officer
December 15, 2020 -
PR Newswire
Innovent Announces First Patient Dosed in Phase 2 Pivotal Trial of IBI310 (CTLA-4) combined with TYVYT® (sintilimab injection) for the treatment of second-line or above Advanced Cervical Cancer
December 10, 2020 -
GlobeNewswire
Ultragenyx Announces Orphan Drug Designation for UX701 for the Treatment of Wilson Disease
December 9, 2020 -
GlobeNewswire
Orchard Therapeutics Reports OTL-201 Initial Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA)
December 8, 2020 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate CMP-001 in Combination with Nivolumab
December 8, 2020 -
Crunchbase
Centivo Secures $34M Series B To Scale Self-funded Employer Health Plan
December 7, 2020 -
PR Newswire
Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
December 7, 2020 -
GlobeNewswire
Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and R/R B-cell Acute Lymphoblastic Leukemia (B-ALL)
December 4, 2020 -
GlobeNewswire
Adagene Announces Expansion of Leadership Team to Support Strategic Growth
December 2, 2020 -
Business Wire
Turnstone Biologics Announces First Patients Enrolled in Phase 1/2 Clinical Trial Evaluating RIVAL-01 For the Treatment of Solid Tumors
December 1, 2020 -
PR Newswire
Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer
December 1, 2020 -
PR Newswire
Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020
November 22, 2020 -
FierceBiotech
Lilly, Precision Biosciences team up on Duchenne gene therapy in $135M deal
November 20, 2020 -
GlobeNewswire
Orchard Therapeutics Announces FDA Clearance of IND Application for OTL-200 for Metachromatic Leukodystrophy (MLD)
November 19, 2020 -
Business Wire
Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell Therapies
November 18, 2020 -
GlobeNewswire
Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of PNH
November 16, 2020 -
PR Newswire
Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology
November 15, 2020 -
GlobeNewswire
Surface Oncology Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ongoing Phase 1 Clinical Trials
November 13, 2020 -
GlobeNewswire
Beam Therapeutics Presents First Data Highlighting Base Editing Program for Glycogen Storage Disease Type Ia at AASLD
November 13, 2020 -
Business Wire
Xilio Therapeutics Presents Promising Preclinical Tumor-Selective Efficacy and Safety Data for XTX201 (IL-2) and XTX101 (anti-CTLA-4) at SITC
November 12, 2020 -
Business Wire
Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study
November 10, 2020 -
PR Newswire
PatientPing Partners with MedAllies to Ensure Hospital Partners’ Compliance with CMS E-Notifications Condition of Participation
November 10, 2020 -
GlobeNewswire
Denali Therapeutics Announces First Human Biomarker Proof of Concept for Its Transport Vehicle (TV) Technology Achieved in Phase 1/2 Study of ETV:IDS (DNL310) in Hunter Syndrome (MPS II)
November 10, 2020 -
PR Newswire
Innovent Releases Phase 1a Results of CD47 Monoclonal Antibody (Letaplimab) in Monotherapy for Advanced Malignancies at SITC 2020
November 10, 2020 -
GlobeNewswire
Two Confirmed Responses and Five out of Six Patients with Initial Tumor Reductions from Early Dose Cohorts of SURPASS Trial, Presented at SITC
November 9, 2020 -
PR Newswire
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
November 9, 2020 -
GlobeNewswire
Beam Therapeutics Names First CAR-T Base Editing Development Candidate for the Treatment of T-ALL and Presents New Data at SITC 2020
November 9, 2020 -
GlobeNewswire
Orchard Therapeutics Announces New OTL-201 Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) Accepted for Oral Presentation at 62nd American Society of Hematology Annual Meeting
November 5, 2020 -
GlobeNewswire
Innovent and Lilly Jointly Announce Results of Seven Clinical Studies of TYVYT® (sintilimab injection) to Be Presented at the ESMO ASIA Congress 2020
November 4, 2020 -
PR Newswire
Sana Biotechnology Announces Acquisition of Oscine
October 30, 2020 -
Endpoints News
Chinese rare disease player inks first deal around narcolepsy drug Wakix after grabbing $80M to build an ecosystem
October 28, 2020 -
Business Wire
Baptist Health Engages Kyruus to Enable Next-Generation Online Patient Access Experience
October 27, 2020 -
PR Newswire
Apricus Health Partners with Medicare Advantage Plan Devoted Health and Full-Service Retail Pharmacy Liton Rx
October 27, 2020 -
PR Newswire
Arcadia Expands Partnership with PatientPing, Enhancing Access to Real-Time Patient Data for Healthcare Organizations
October 27, 2020 -
The Irish Sun
Irish device that kills 99.999 per cent of Covid in air ‘could help end lockdown’ and get businesses open
October 26, 2020 -
GlobeNewswire
Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy
October 23, 2020 -
GlobeNewswire
Orchard Therapeutics CEO Bobby Gaspar, M.D., Ph.D., Appointed to the Alliance for Regenerative Medicine’s 2021 Board of Directors
October 22, 2020
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.